Various significances of PGRN levels were found: PGRN was lower in AD and DLB compared to FTLD-TDP and FTLD-tau, and there was only a weak difference between prion disease and FTLD-tau (Fig. 1c). This evidence concerns the gene MAPT and Lewy body dementia.